These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15662100

  • 1. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z, Skuza G, Wójcikowski J, Daniel WA, Wróbel A, Dudek D, Zieba A.
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [Abstract] [Full Text] [Related]

  • 2. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z, Dziedzicka-Wasylewska M, Daniel WA, Wójcikowski J, Dudek D, Wróbel A, Zieba A.
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [Abstract] [Full Text] [Related]

  • 3. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G, Siwek M, Dudek D, Zieba A, Pilc A.
    Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
    [Abstract] [Full Text] [Related]

  • 4. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G.
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [Abstract] [Full Text] [Related]

  • 5. Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression.
    Rogóz Z, Skuza G, Daniel WA, Wójcikowski J, Dudek D, Wróbel A.
    Pharmacol Rep; 2007 Nov; 59(6):778-84. PubMed ID: 18195470
    [Abstract] [Full Text] [Related]

  • 6. Effect of combined treatment with imipramine and metyrapone on the immobility time, the activity of hypothalamo-pituitary-adrenocortical axis and immunological parameters in the forced swimming test in the rat.
    Rogóz Z, Budziszewska B, Kubera M, Basta-Kaim A, Jaworska-Feil L, Skuza G, Lasoń W.
    J Physiol Pharmacol; 2005 Mar; 56(1):49-61. PubMed ID: 15795475
    [Abstract] [Full Text] [Related]

  • 7. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W, Siwek M, Dudek D, Maczka G, Zieba A.
    Psychiatr Pol; 2007 Mar; 41(3):339-49. PubMed ID: 17900050
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 9. Combined treatment with imipramine and mianserin. A controlled pilot study.
    Lauritzen L, Clemmesen L, Klysner R, Loldrup D, Lunde M, Schaumburg E, Waarst S, Bech P.
    Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
    [Abstract] [Full Text] [Related]

  • 10. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
    Prasko J, Horacek J, Klaschka J, Kosova J, Ondrackova I, Sipek J.
    Neuro Endocrinol Lett; 2002 Apr; 23(2):109-13. PubMed ID: 12011795
    [Abstract] [Full Text] [Related]

  • 11. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation.
    Thase ME, Kupfer DJ, Frank E, Jarrett DB.
    J Clin Psychiatry; 1989 Nov; 50(11):413-7. PubMed ID: 2509437
    [Abstract] [Full Text] [Related]

  • 12. Imipramine blood levels and clinical outcome.
    Rigal JG, Albin HC, Duchier AR, D'Aulnay JM, Fenelon JH, Vincon GA, Demotes-Mainard FM.
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [Abstract] [Full Text] [Related]

  • 13. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J, Wasieczko A.
    Psychiatr Pol; 1991 Aug; 25(1):54-60. PubMed ID: 1780375
    [Abstract] [Full Text] [Related]

  • 14. [Monitoring of the treatment of endogenous depression with imipramine and amitriptyline (preliminary report)].
    Rybakowski J, Matkowski K, Linka M, Kasprowicz-Dabrowiecka A, Kanarkowski R, Lehmann W, Krzyzanowski M.
    Psychiatr Pol; 1991 Aug; 25(3-4):111-8. PubMed ID: 1821970
    [Abstract] [Full Text] [Related]

  • 15. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
    Thase ME, Kupfer DJ, Jarrett DB.
    J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
    [Abstract] [Full Text] [Related]

  • 16. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH, Weller EB, Weller RA.
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of the treatment with tetracyclic and tricyclic antidepressants in patients with minor depressive disorders.
    Tudor S, Zaharia M.
    Rom J Neurol Psychiatry; 1994 Nov; 32(3):185-98. PubMed ID: 7710969
    [Abstract] [Full Text] [Related]

  • 18. [The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. A pilot study].
    Dudek D, Siwek M, Borowiecka-Kluza J.
    Psychiatr Pol; 2008 Nov; 42(2):283-94. PubMed ID: 19697533
    [Abstract] [Full Text] [Related]

  • 19. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
    Strober M, Freeman R, Rigali J, Schmidt S, Diamond R.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.